Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?
Depot medroxyprogesterone acetate users exhibit decreased endometrial tissue inhibitors of metalloproteinases and increased T lymphocytes, suggesting an altered matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in abnormal uterine bleeding.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (44)
- Changes in vascular basement membrane in the endometrium of Norplant users via openalex
- Dating the Endometrial Biopsy via openalex
- Progesterone receptor in Norplant(R) endometrium via openalex
- Secretion of matrix metalloproteinases by human endometrial cells <i>in vitro</i> via openalex
- The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation via openalex
- doi:10.1093/humrep/11.suppl_2.124 via openalex
- doi:10.1093/oxfordjournals.humrep.a019300 via openalex
- doi:10.1093/oxfordjournals.humrep.a019474 via openalex
- doi:10.1093/humrep/13.5.1210 via openalex
- doi:10.1093/molehr/3.9.735 via openalex
- doi:10.1016/s0165-0378(00)00082-6 via openalex
- doi:10.1016/s0960-0760(97)00119-2 via openalex
- doi:10.1073/pnas.93.17.9120 via openalex
- doi:10.1093/humrep/11.suppl_2.165 via openalex
- doi:10.1530/jrf.0.1070043 via openalex
- doi:10.1177/10454411930040020401 via openalex
- doi:10.1095/biolreprod59.3.693 via openalex
- doi:10.1053/beog.1999.0018 via openalex
- doi:10.1093/humrep/14.3.793 via openalex
- doi:10.1093/humupd/6.1.16 via openalex
- doi:10.1111/j.1600-0897.1995.tb00956.x via openalex
- doi:10.1016/0010-7824(91)90075-q via openalex
- doi:10.1093/humrep/11.suppl_2.31 via openalex
- doi:10.1080/00140137208928231 via openalex
- doi:10.1210/jcem.85.12.7020 via openalex
- doi:10.1093/humrep/15.suppl_3.162 via openalex
- doi:10.1093/humrep/15.suppl_3.135 via openalex
- doi:10.1677/joe.0.141r001 via openalex
- doi:10.1093/oxfordjournals.humrep.a137904 via openalex
- doi:10.1093/humrep/15.suppl_3.120 via openalex
- doi:10.1016/s0165-0378(02)00011-6 via openalex
- doi:10.1093/molehr/7.6.559 via openalex
- doi:10.1172/jci117461 via openalex
- doi:10.1016/s1071-5576(97)86381-2 via openalex
- doi:10.1093/humrep/15.1.123 via openalex
- doi:10.1016/0303-7207(94)03442-v via openalex
- doi:10.1093/oxfordjournals.humrep.a135750 via openalex
- doi:10.1074/jbc.270.28.16518 via openalex
- doi:10.1093/humrep/11.suppl_2.35 via openalex
- doi:10.1016/s0002-9378(16)32491-7 via openalex
- doi:10.1093/humrep/11.suppl_2.45 via openalex
- doi:10.1093/oxfordjournals.humrep.a019416 via openalex
- doi:10.1093/humrep/13.5.1218 via openalex
- doi:10.2307/1271101 via openalex
Cited by (9)
- The uterine natural killer cell, cytotoxic T lymphocyte, and granulysin levels are elevated in the endometrium of women with nonstructural abnormal uterine bleeding 2022
- Matrix metalloproteinases-2, -7 and tissue metalloproteinase inhibitor-1 expression in human endometrium 2018
- Abnormal bleeding in postmenopausal hormone users—What do we know today? 2009
- Best Practice & Research Clinical Obstetrics and Gynaecology 2009
- Bleeding with menopausal hormone therapy 2008
- Endometrial bleeding during hormone therapy: The effect of progestogens 2007
- Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users 2006
- Mechanisms of Irregular Bleeding with Hormone Therapy: The Role of Matrix Metalloproteinases and Their Tissue Inhibitors 2006
- Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding 2003
Source provenance
- openalex
- last seen: 2026-05-11T05:53:22.067783+00:00